1. European Medicines Agency. ICH E9 (R1.) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials [Internet]. Verfügbar unter: https://www.ema.europa.eu/en/ich-e9-statistical-principles-clinical-trials-scientific-guideline.
2. Beyer U, Dejardin D, Meller M, Rufibach K, Burger HU. A multistate model for early decision-making in oncology. Biom J Mai. 2020;62(3):550–67.
3. Erdmann A, Beyersmann J, Rufibach K. Oncology clinical trial design planning based on a multistate model that jointly models progression-free and overall survival endpoints. 2023 [zitiert 13. Februar 2024]; Verfügbar unter: https://arxiv.org/abs/2301.10059.
4. Wolkewitz M, Cooper BS, Bonten MJM, Barnett AG, Schumacher M. Interpreting and comparing risks in the presence of competing events. BMJ 21 August. 2014;349(aug21 5):g5060–5060.
5. Schumacher M, Allignol A, Beyersmann J, Binder N, Wolkewitz M. Hospital-acquired infections–appropriate statistical treatment is urgently needed! Int J Epidemiol 1 Oktober. 2013;42(5):1502–8.